Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

[The epidemiological surveillance in the programme of public health intervention in the national priority contaminated sites of Sicily Region (Southern Italy): update of mortality, hospitalization, and cancer incidence].

Cernigliaro A, Santangelo OE, Maniglia M, Pollina Addario S, Usticano A, Marras A, Ciranni P, Dardanoni G, Saporito L, Tavormina E, Fantaci G, Scondotto S.

Epidemiol Prev. 2019 Mar-Jun;43(2-3):132-143. doi: 10.19191/EP19.2-3.P132.052. Italian.

PMID:
31293132
2.

[Survey on the Prevalence of Rare Kidney Diseases in Sicily].

Maringhini S, Cusumano R, Miceli P, Castellino S, Chimenz R, Dardanoni G, Ferrantelli A, Granata A, Santoro D, Scondotto S.

G Ital Nefrol. 2019 Feb;36(1). pii: 2019-vol1. Italian.

PMID:
30758154
3.

β-Thalassemia heterozygote state detrimentally affects health expectation.

Graffeo L, Vitrano A, Scondotto S, Dardanoni G, Pollina Addario WS, Giambona A, Sacco M, Di Maggio R, Renda D, Taormina F, Triveri A, Attanasio M, Gluud C, Maggio A.

Eur J Intern Med. 2018 Aug;54:76-80. doi: 10.1016/j.ejim.2018.06.009. Epub 2018 Jun 19. Review.

PMID:
29934240
4.

Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics.

Tavarelli M, Malandrino P, Vigneri P, Richiusa P, Maniglia A, Violi MA, Sapuppo G, Vella V, Dardanoni G, Vigneri R, Pellegriti G.

Front Endocrinol (Lausanne). 2017 Oct 20;8:277. doi: 10.3389/fendo.2017.00277. eCollection 2017.

5.

Congenital Anomalies in Contaminated Sites: A Multisite Study in Italy.

Santoro M, Minichilli F, Pierini A, Astolfi G, Bisceglia L, Carbone P, Conti S, Dardanoni G, Iavarone I, Ricci P, Scarano G, Bianchi F; RiscRipro Sentieri Working Group.

Int J Environ Res Public Health. 2017 Mar 10;14(3). pii: E292. doi: 10.3390/ijerph14030292.

6.

The heterozygote state for β-thalassemia detrimentally affects health outcomes.

Graffeo L, Vitrano A, Giambona A, Scondotto S, Dardanoni G, Gluud C, Maggio A.

Am J Hematol. 2017 Mar;92(3):E23-E25. doi: 10.1002/ajh.24619. Epub 2017 Feb 1. No abstract available.

7.

[Reproductive health in high environmental risk areas in Sicily Region (Southern Italy) in the period 2007-2013].

Cernigliaro A, Tavormina E, Dardanoni G, Scondotto S.

Epidemiol Prev. 2016 Mar-Apr;40(3-4):197-204. doi: 10.19191/EP16.3-4.P197.086. Italian.

PMID:
27436253
8.

Several Site-specific Cancers are Increased in the Volcanic Area in Sicily.

Russo M, Malandrino P, Addario WP, Dardanoni G, Vigneri P, Pellegriti G, Squatrito S, Vigneri R.

Anticancer Res. 2015 Jul;35(7):3995-4001.

PMID:
26124347
9.

Descriptive epidemiology of human thyroid cancer: experience from a regional registry and the "volcanic factor".

Malandrino P, Scollo C, Marturano I, Russo M, Tavarelli M, Attard M, Richiusa P, Violi MA, Dardanoni G, Vigneri R, Pellegriti G.

Front Endocrinol (Lausanne). 2013 Jun 4;4:65. doi: 10.3389/fendo.2013.00065. eCollection 2013.

10.

[The diffusion of screening programmes in Italy, year 2010].

Zappa M, Dardanoni G, Giorgi Rossi P, Grazzini G, Naldoni C, Paci E, Pirola ME, Pizzuti R, Segnan N, Zorzi M, Federici A.

Epidemiol Prev. 2012 Nov-Dec;36(6 Suppl 1):3-7. Italian.

11.

Comorbidities and survival in obstructive sleep apnoea beyond the age of 50.

Marrone O, Lo Bue A, Salvaggio A, Dardanoni G, Insalaco G.

Eur J Clin Invest. 2013 Jan;43(1):27-33. doi: 10.1111/eci.12011. Epub 2012 Oct 28.

PMID:
23106598
12.

Mortality and morbidity study of petrochemical employees in a polluted site.

Pasetto R, Zona A, Pirastu R, Cernigliaro A, Dardanoni G, Addario SP, Scondotto S, Comba P.

Environ Health. 2012 May 18;11:34. doi: 10.1186/1476-069X-11-34.

13.

The diffusion of screening programmes in Italy, year 2009.

Zappa M, Dardanoni G, Giorgi Rossi P, Grazzini G, Naldoni C, Paci E, Pirola ME, Pizzuti R, Segnan N, Zorzi M, Federici A.

Epidemiol Prev. 2011 Sep-Dec;35(5-6 Suppl 5):3-7. English, Italian.

14.

[Socioeconomic disparities in mortality among older people in Sicily].

Cernigliaro A, Cesaroni G, Pollina Addario S, Dardanoni G, Forastiere F, Scondotto S, Perucci CA.

Epidemiol Prev. 2009 Jul-Oct;33(4-5):169-75. Italian.

15.

[The experience of the Sicilian epidemiology observatory in studying health status of population resident in Gela risk area].

Cernigliaro A, Pollina Addario S, Fantaci G, Tavormina E, Dardanoni G, Scondotto S.

Epidemiol Prev. 2009 May-Jun;33(3 Suppl 1):84-8. Italian. No abstract available.

16.

Papillary thyroid cancer incidence in the volcanic area of Sicily.

Pellegriti G, De Vathaire F, Scollo C, Attard M, Giordano C, Arena S, Dardanoni G, Frasca F, Malandrino P, Vermiglio F, Previtera DM, D'Azzò G, Trimarchi F, Vigneri R.

J Natl Cancer Inst. 2009 Nov 18;101(22):1575-83. doi: 10.1093/jnci/djp354. Epub 2009 Nov 5.

PMID:
19893009
17.

[Dynamics of recovery for breast neoplasms in Sicily and incidence rate of surgical procedures].

Dardanoni G, Addario SP.

Epidemiol Prev. 2009 Jan-Apr;33(1-2 Suppl 1):27-32. Italian. No abstract available.

18.

[Mortality of breast neoplasm in Sicily].

Cernigliaro A, Miceli P, Addario SP, Tavormina E, Marras A, Scondotto S, Dardanoni G.

Epidemiol Prev. 2009 Jan-Apr;33(1-2 Suppl 1):9-16. Italian. No abstract available.

19.

[Estimating the incidence of breast neoplasms in the region and provinces of Sicily].

Fantaci G, Tavormina E, Addario SP, Scondotto S, Dardanoni G, De Angelis R, Grande E, Francisci S.

Epidemiol Prev. 2009 Jan-Apr;33(1-2 Suppl 1):17-26. Italian. No abstract available.

20.

[Congenital malformations in newborns residing in the municipality of Gela (Sicily, Italy)].

Bianchi F, Bianca S, Dardanoni G, Linzalone N, Pierini A.

Epidemiol Prev. 2006 Jan-Feb;30(1):19-26. Italian.

21.

Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

Bazan V, Bruno L, Augello C, Agnese V, Calò V, Corsale S, Gargano G, Terrasi M, Schirò V, Di Fede G, Adamo V, Intrivici C, Crosta A, Rinaldi G, Latteri F, Dardanoni G, Grassi N, Valerio MR, Colucci G, Macaluso M, Russo A; Gruppo Oncologico dell'Italia Meridionale.

Ann Oncol. 2006 Jun;17 Suppl 7:vii84-90.

PMID:
16760301
22.

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

Iacopetta B, Russo A, Bazan V, Dardanoni G, Gebbia N, Soussi T, Kerr D, Elsaleh H, Soong R, Kandioler D, Janschek E, Kappel S, Lung M, Leung CS, Ko JM, Yuen S, Ho J, Leung SY, Crapez E, Duffour J, Ychou M, Leahy DT, O'Donoghue DP, Agnese V, Cascio S, Di Fede G, Chieco-Bianchi L, Bertorelle R, Belluco C, Giaretti W, Castagnola P, Ricevuto E, Ficorella C, Bosari S, Arizzi CD, Miyaki M, Onda M, Kampman E, Diergaarde B, Royds J, Lothe RA, Diep CB, Meling GI, Ostrowski J, Trzeciak L, Guzinska-Ustymowicz K, Zalewski B, Capellá GM, Moreno V, Peinado MA, Lönnroth C, Lundholm K, Sun XF, Jansson A, Bouzourene H, Hsieh LL, Tang R, Smith DR, Allen-Mersh TG, Khan ZA, Shorthouse AJ, Silverman ML, Kato S, Ishioka C; TP53-CRC Collaborative Group.

Ann Oncol. 2006 May;17(5):842-7. Epub 2006 Mar 8.

PMID:
16524972
23.
24.

TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.

Russo A, Corsale S, Agnese V, Macaluso M, Cascio S, Bruno L, Surmacz E, Dardanoni G, Valerio MR, Vieni S, Restivo S, Fulfaro F, Tomasino RM, Gebbia N, Bazan V.

J Cell Physiol. 2006 Jan;206(1):181-8.

PMID:
15965904
25.

Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study.

Bazan V, Agnese V, Corsale S, Calò V, Valerio MR, Latteri MA, Vieni S, Grassi N, Cicero G, Dardanoni G, Tomasino RM, Colucci G, Gebbia N, Russo A; Gruppo Oncologico dell'Italia Meridionale (GOIM).

Ann Oncol. 2005 May;16 Suppl 4:iv50-55.

PMID:
15923430
26.

Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer.

Calascibetta A, Cabibi D, Martorana A, Sanguedolce G, Rausa L, Feo S, Dardanoni G, Sanguedolce R.

Anticancer Res. 2004 Nov-Dec;24(6):3875-80.

27.

Clinical relevance of thymidylate synthase expression in the signet ring cell histotype component of colorectal carcinoma.

Cabibi D, Calascibetta A, Campione M, Barresi E, Rausa L, Dardanoni G, Aragona F, Sanguedolce R.

Eur J Cancer. 2004 Dec;40(18):2845-50.

PMID:
15571969
28.

TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome.

Migliavacca M, Ottini L, Bazan V, Agnese V, Corsale S, Macaluso M, Lupi R, Dardanoni G, Valerio MR, Pantuso G, Di Fede G, Tomasino RM, Gebbia N, Mariani-Costantini R, Russo A.

J Cell Physiol. 2004 Sep;200(3):476-85.

PMID:
15254976
29.

Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects: The Casteldaccia Eye Study.

Giuffrè G, Lodato G, Dardanoni G.

Graefes Arch Clin Exp Ophthalmol. 2004 Jul;242(7):535-40. Epub 2004 Feb 18.

PMID:
14991334
30.

Nm23-H1 expression does not predict clinical survival in colorectal cancer patients.

Dusonchet L, Corsale S, Migliavacca M, Calò V, Bazan V, Amato A, Cammareri P, Totaro MS, Agnese V, Cascio S, La Rocca G, Sisto PS, Dardanoni G, Valerio MR, Grassi N, Latteri S, Cajozzo M, Buscemi M, Castorina S, Morello V, Tomasino RM, Gebbia N, Russo A.

Oncol Rep. 2003 Sep-Oct;10(5):1257-63.

PMID:
12883690
31.

Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough.

Giammanco A, Taormina S, Chiarini A, Dardanoni G, Stefanelli P, Salmaso S, Mastrantonio P.

Vaccine. 2003 May 16;21(17-18):1924-31.

PMID:
12706678
32.

DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.

Bazan V, Migliavacca M, Zanna I, Tubiolo C, Corsale S, Calò V, Amato A, Cammareri P, Latteri F, Grassi N, Fulfaro F, Porcasi R, Morello V, Nuara RB, Dardanoni G, Salerno S, Valerio MR, Dusonchet L, Gerbino A, Gebbia N, Tomasino RM, Russo A.

J Cancer Res Clin Oncol. 2002 Dec;128(12):650-8. Epub 2002 Nov 15.

PMID:
12474051
33.

p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.

Russo A, Migliavacca M, Zanna I, Valerio MR, Latteri MA, Grassi N, Pantuso G, Salerno S, Dardanoni G, Albanese I, La Farina M, Tomasino RM, Gebbia N, Bazan V.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1322-31.

34.

Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.

Bazan V, Migliavacca M, Zanna I, Tubiolo C, Grassi N, Latteri MA, La Farina M, Albanese I, Dardanoni G, Salerno S, Tomasino RM, Labianca R, Gebbia N, Russo A.

Ann Oncol. 2002 Sep;13(9):1438-46.

PMID:
12196370
35.

Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma.

Bazan V, Zanna I, Migliavacca M, Sanz-Casla MT, Maestro ML, Corsale S, Macaluso M, Dardanoni G, Restivo S, Quintela PL, Bernaldez R, Salerno S, Morello V, Tomasino RM, Gebbia N, Russo A.

J Cell Physiol. 2002 Sep;192(3):286-93.

PMID:
12124774
36.

Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?

Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Amato A, Calò V, Dardanoni G, Morello V, La Farina M, Albanese I, Tomasino RM, Gebbia N, Russo A.

J Cell Physiol. 2002 May;191(2):237-46.

PMID:
12064467
37.

Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: clinical implications.

Leto G, Tumminello FM, Gebbia N, Bazan V, Tomasino RM, Dardanoni G, Russo A.

Int J Biol Markers. 2001 Oct-Dec;16(4):245-9.

PMID:
11820719
38.

DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study.

Russo A, Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Latteri F, Valerio MR, Pantuso G, Morello V, Dardanoni G, Latteri MA, Colucci G, Tomasino RM, Gebbia N.

Cancer. 2001 Jul 15;92(2):294-302.

PMID:
11466682
39.

Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.

Russo A, Bazan V, Migliavacca M, Zanna I, Tubiolo C, Tumminello FM, Dardanoni G, Cajozzo M, Bazan P, Modica G, Latteri M, Tomasino RM, Colucci G, Gebbia N, Leto G.

Clin Cancer Res. 2000 Jan;6(1):178-84.

40.

Pseudocysts in acute nonalcoholic pancreatitis: incidence and natural history.

Maringhini A, Uomo G, Patti R, Rabitti P, Termini A, Cavallera A, Dardanoni G, Manes G, Ciambra M, Laccetti M, Biffarella P, Pagliaro L.

Dig Dis Sci. 1999 Aug;44(8):1669-73.

PMID:
10492151
41.

Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.

Alderisio M, Cenci M, Valli C, Russo A, Bazan V, Dardanoni G, Cucciarre S, Carreca I, Macaluso MP, Tomasino RM, Vecchione A.

Anticancer Res. 1998 Nov-Dec;18(6A):4225-30.

PMID:
9891471
42.

Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases.

Russo A, Migliavacca M, Bazan V, Maturi N, Morello V, Dardanoni G, Modica G, Bazan P, Albanese I, La Farina M, Tomasino RM.

Cell Prolif. 1998 Jun-Aug;31(3-4):139-53.

PMID:
9853427
43.

Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain.

Mercadante S, Salvaggio L, Dardanoni G, Agnello A, Garofalo S.

J Pain Symptom Manage. 1998 Feb;15(2):76-81.

PMID:
9494305
44.

Opioid-sparing effect of diclofenac in cancer pain.

Mercadante S, Sapio M, Caligara M, Serretta R, Dardanoni G, Barresi L.

J Pain Symptom Manage. 1997 Jul;14(1):15-20.

PMID:
9223838
45.

Monitoring of opioid therapy in advanced cancer pain patients.

Mercadante S, Dardanoni G, Salvaggio L, Armata MG, Agnello A.

J Pain Symptom Manage. 1997 Apr;13(4):204-12.

PMID:
9136231
46.

ras and myc analysis in primary and metastatic colorectal carcinomas.

Albanese I, Rinaudo C, Alberti M, Bazan V, Russo A, Migliavacca M, Bazan P, Dardanoni G, Tomasino R, Lafarina M.

Int J Oncol. 1997 Feb;10(2):293-300.

PMID:
21533375
47.

Flow cytometric S-phase fraction as an independent prognostic indicator in colorectal liver metastases.

Migliavacca M, Bazan V, Maturi N, Morello V, Dardanoni G, Bazan P, Modica G, Albanese I, La Farina M, Tomasino RM, Russo A.

Eur J Histochem. 1997;41 Suppl 2:137-8. No abstract available.

PMID:
9859819
48.

Ascites, pleural, and pericardial effusions in acute pancreatitis. A prospective study of incidence, natural history, and prognostic role.

Maringhini A, Ciambra M, Patti R, Randazzo MA, Dardanoni G, Mancuso L, Termini A, Pagliaro L.

Dig Dis Sci. 1996 May;41(5):848-52.

PMID:
8625753
49.

Pleomorphic adenoma and adenoid-cystic carcinoma of salivary glands: immunohistochemical assessment of proliferative activity in comparison with flow-cytometric study.

Daniele E, Tralongo V, Morello V, Nagar C, Russo A, Bazan V, Dardanoni G, Ciotta S, Nuara R, Tomasino RM.

Cell Prolif. 1996 Mar;29(3):153-62.

PMID:
8652744
50.

nm23-H1 protein immunohistochemical expression in human breast cancer.

Russo A, Bazan V, Morello V, Valli C, Giarnieri E, Dardanoni G, Cucciarre S, Carreca I, Bazan P, Tomasino R, Vecchione A.

Oncol Rep. 1996 Jan;3(1):183-9.

PMID:
21594341

Supplemental Content

Loading ...
Support Center